Stay updated with breaking news from Marc Engelhardt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal...
The approval was based on data from multiple studies, including ERADICATE, TARGET, and a phase 3 study in CABP.
Cases so far this year are triple the same period last year, and the WHO said more outbreak resources are needed, including access to vaccines.
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 04, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the...
Basilea Pharmaceutica announced the FDA approved ZEVTERA for the treatment of adult patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis, and adult patients with acute bacterial skin and skin structure infections and for adult and pediatric patients with community-acquired bacterial pneumonia.